Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

AAX Biotech Awarded AbbVie Scandinavia Golden Ticket

AAX Biotech is happy to announce its selection as the winner of the AbbVie Scandinavia Golden Ticket. This award grants AAX Biotech access to the SmiLe Incubator's collection of resources, including laboratory and office space, as well as mentoring and business development support, enhancing its efforts in developing antibody-based therapeutics.AAX Biotech is a Swedish startup biotech company aiming to solve unmet needs in developing next-generation antibody therapeutics. The company's two unique and patentable technologies, Seqitope™ and Opti-mAb™, improve the performance and

Vantaa Energy chooses AFRY as EPCM service provider of the world’s largest cavern thermal energy storage

AFRY has been commissioned by Vantaa Energy, one of Finland’s largest city energy companies, for engineering, procurement, and construction management services (EPCM) for a seasonal energy storage in the city of Vantaa, Finland. The cavern thermal energy storage is set to be the world's largest, storing energy produced from industrial waste heat, waste-to-energy processes, and electric boilers powered by renewable electricity. The unique project will benefit from AFRY’s extensive expertise and strength in all necessary engineering disciplines, including rock, civil, energy, process and plant

Getinge receives EU MDR approval of Advanta V12 covered stent system with use for patients with renal artery stenosis and/or aortoiliac occlusive disease

Getinge announces the EU MDR certification of its Advanta V12 covered stent system, highlighting its use for patients with aortoiliac occlusive disease, including lesions at the aortic bifurcation. This approval affirms the system's compliance with European Union medical device regulations and aligns its application, reflecting Getinge's commitment to quality and patient safety. Getinge, a pioneer in balloon-expandable covered stents, announces the recent achievement of an EU MDR certificate for Advanta V12, that now aligns the indication to Aortoiliac Occlusive Disease (AIOD).

Notice to attend the Annual General Meeting of Bactiguard Holding AB

The shareholders of Bactiguard Holding AB (publ), company reg. no. 556822-1187 (“Bactiguard”), are hereby given notice to attend the Annual General Meeting (AGM) to be held on Tuesday, 14 May 2024 at 10 am at Posthuset 7A, Vasagatan 28 in Stockholm. Registration will commence at 9 am.Right to participate and notice of intent to participate Shareholders wishing to participate in the Annual General Meeting must: · be recorded in the share register maintained by Euroclear Sweden AB (“Euroclear”) on Friday 3 May 2024 (“the record date”) · provide notice to the company of their intent

Invitation to presentation of Pandox’s interim report January–March 2024

Pandox AB (publ) publishes the interim report for the period January–March 2024 on 25 April 2024, at 07:00 CEST, followed by a webcasted telephone conference at 08:30 CEST. Afterwards, a proprietary presentation on the international hotel market, separate from Pandox’s earnings presentation, will be held by Thomas Emanuel, Senior Director, STR International. Teleconference If you wish to participate via teleconference, please register via the following link: https://conference.financialhearings.com/teleconference/?id=5009919 

SmartCraft ASA (SMCRT) - Notice of Annual General Meeting 2024

11 April 2024 - SmartCraft ASA's Annual General Meeting will be held on 2 May 2024, at 10:00 CEST as a digital meeting without physical attendance. The notice including agenda for the meeting, power of attorney form and registration form is attached to this disclosure and will be sent to shareholders. The following documents as well as a link to a digital registration form can be found on our website at https://smartcraft.com/investor-relations/general-meeting/  * Annual Report 2023  * Remuneration Report 2023  * Proposal from the Nomination Committee for AGM 2024 The

Nordic Bioproducts Group and Thailand’s PTT MCC Biochem Co. Ltd. forge a strategic partnership to advance bioplastic innovation for everyday items

The Finnish startup has formed an MOU with one of the world’s leading bioplastic producers. This strategic collaboration aims to advance the performance and compostability of bioplastics, facilitating their use across a wide range of single-use products, such as coffee capsules, while displacing traditional plastics.Nordic Bioproducts Group (NBG) , a biomaterial innovation company and developer of pioneering AaltoCell Technology, has entered into a strategic Memorandum of Understanding (MOU) with PTT MCC Biochem Company Limited (PTT MCC) headquartered in

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 84 – 11 APRIL 2024   In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 30/24 and 31/24.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Stig Frederiksen, Head of Communications & Investor Relations, tel.: +45 32 71 08 55, e-mail: sfr@norden.com

Invitation to conference call and webcast presentation of Metsä Board's January–March 2024 results

Metsä Board Corporation Investor News 11 April 2024Metsä Board will publish its interim report for January–March 2024 on Thursday 25 April 2024 at 12:00 noon EEST. The release and related presentation material will be available after publishing on the company's website at https://www.metsagroup.com/metsaboard/investors/. A webcast and a conference call for analysts and investors in English will be held on the same day at 3:00 p.m. EEST. CEO Mika Joukio and CFO Henri Sederholm will present the results. The webcast and conference call can be followed online on the company’s website at

Invitation to the presentation of Axfood’s first quarter 2024

Axfood invites investors, analysts and the press to a presentation of the interim report for the first quarter 2024 at 9:30 am CET on 25 April. The report will be published at 7:00 am CET the same day.Axfood’s President and CEO Klas Balkow will present the report together with CFO Anders Lexmon. The presentation will be held in English. Time: Thursday, 25 April at 9:30 am CET To follow the presentation webcast, please use this link . To participate via teleconference, please register via this link 

Bahamas port goes electric with Konecranes Gottwald Generation 6 Mobile Harbor Crane

Arawak Port Development Limited (APD) has ordered a Konecranes Gottwald ESP.6 mobile harbor crane to add substantial extra capacity to their terminal at the Port of Nassau. This crane will be the first at the port to run on mains power, which means zero emissions during operation. The crane was ordered in Q1 2024 and will be delivered in Q3 2024. APD operates one of the largest port facilities in the Caribbean, and is expanding its Nassau facilities with new container handling equipment to keep pace with growing demand. With one Konecranes Gottwald Generation 6 mobile harbor crane

Christian Kinch assumes role as senior advisor to Bactiguard and declines re-election to the board

The Nomination Committee of Bactiguard Holding AB (the "Company") today informs about the proposal regarding the composition of the Board of Directors for the Annual General Meeting on 14 May 2024.The Nomination Committee proposes reelection of Thomas von Koch, Dr Richard Kuntz, Professor Anna Martling, Magdalena Persson and Jan Ståhlberg as Board Members. Christian Kinch has declined re-election. As the Company has appointed a new permanent CEO with effect from the Annual General Meeting at the latest, the Nomination Committee further proposes that Thomas von Koch is re-elected as the

Invitation to the presentation of Midsona’s interim report January- March 2024

Midsona invites you to a presentation of the company’s interim report January-March 2024 on Thursday, April 25, 2024, at 11.00 am CEST. The report will be published the same day at 08.00 am CEST.CEO Peter Åsberg and CFO Max Bokander will present the results. After the presentation, there will be an opportunity to ask questions. The presentation will be held in English.   The webcast can be accessed via this link: https://ir.financialhearings.com/midsona-q1-report-2024 To attend the presentation via teleconference and to ask questions, please klick on the link. After your

Icore Solutions acquired by Volaris Group "Helping open doors to new business opportunities"

Icore Solutions announces its acquisition by Volaris Group. The acquisition helps position Icore for continued growth and development.  “By being part of a larger company and having the support of Volaris, we get access to resources and expertise that can help open doors to new business opportunities that were previously inaccessible to us”, says Mikael Boquist, CEO of Icore. Mikael Boquist, CEO Icore Solutions, and Christian Lanng, Portfolio Manager, Nordics and UK & Portfolio COO, Volaris Group. Photo by Fredrik Bankler. Volaris Group specializes in the acquisition and growth

Inwido´s Annual and Sustainability Report for 2023 is published

Inwido´s Annual and Sustainability Report for 2023 is now available on Inwidos website. A printed version of the Annual and Sustainability Report can be ordered on the website, in Swedish and English.Stable development demonstrates the strength of the business model As well as delivering stable profitability, Inwido strengthened its cash flow and ended the year with continued low indebtedness, despite the fact that the Company completed its largest acquisition to date during 2023. The year was characterized by inflation, high interest rates and war in both Europe and the Middle East.

BioStock: BiBB’s CEO - “Patient cases fortify our confidence in EndoDrill”

BiBBInstruments' cancer biopsy device, EndoDrill, has earned high praise from physicians who conducted the first clinical cases at Karolinska University Hospital in Stockholm, Sweden. This positive feedback follows the endorsement of EndoDrill as a "game-changer" in endoscopic ultrasound sampling by the Medical Director of Endoscopy at UC Davis in the US. BioStock spoke with BiBB’s CEO Fredrik Lindblad to learn more.Read the article at biostock.se: https://www.biostock.se/en/2024/04/bibbs-ceo-patient-cases-fortify-our-confidence-in-endodrill/This is a press release from BioStock -

Inhalation Sciences AB (publ) releases Annual Report 2023

Inhalation Sciences AB announces that its Annual Report for 2023 is now available on the company’s website.To read the whole report (in Swedish), visit: http://inhalation.se/investors/finansiella-rapporter/ CEO comments 2023 was another year in which we continued to take new market share and successfully deliver on our strategic goals. Over the past three years, revenue has increased steadily by 29% from 2021 to 2022 and now by 44% from 2022 to 2023. At the same time, we have also significantly improved our operating profit during the same period. With this positive development, we

NOTICE OF ANNUAL GENERAL MEETING IN BALCO GROUP AB (publ)

The shareholders in Balco Group AB, reg. no. 556821-2319, are invited to the Annual General Meeting, to be held on Tuesday May 14, 2024, at 3.00 pm at Kök 11, Honnörsgatan 15 in Växjö. Registration starts at 2.30 pm. The Board of Directors has, pursuant to Chapter 7, Section 4 a of the Swedish Companies Act (Sw. aktiebolagslagen), and Chapter 8 of the company's Articles of Association, decided that shareholders shall be able to exercise their voting rights by postal voting before the General Meeting. Consequently, shareholders may choose to exercise their voting rights at the Annual

CONVENING NOTICE OF ANNUAL GENERAL MEETING OF ORGANOCLICK AB (publ)

Shareholders of OrganoClick AB (publ) (556704-6908) are hereby convened to the Annual General Meeting on Wednesday, May 15, 2024, at 17.00, at OrganoClick's head office and production facility, Linjalvägen 9, 187 66 Täby.PARTICIPATION Shareholders who wish to attend the AGM shall - be registered in OrganoClick’s shareholder register, kept by Euroclear Sweden AB, on Monday May 6, 2024, - no later than Wednesday, May 8, 2024, have notified their attendance, and any advisers, to the meeting. NOTIFICATION OF ATTENDANCE Notification of attendance can be made by email to ir@

Valmet renews its sustainability reporting

Valmet Oyj’s press release on April 11, 2024 at 9:30 a.m. EESTValmet renews its sustainability reporting practices. Since 2013 the company has published an annual sustainability report in line with the international GRI framework and reported to several leading sustainability ratings. In the current renewal, Valmet will focus on comprehensive reporting according to the EU's Corporate Sustainability Reporting Directive (CSRD), invest in the development of sustainability data and information systems required by this extensive reporting framework, and streamline participation in different

Notice of Annual General Meeting for Prevas AB

Unofficial English translation for information purposes only. If there are differences between the English translation and the Swedish original, the Swedish text will take precedence. The shareholders of Prevas AB, corporate registration number 556252-1384, are hereby given notice of the Annual General Meeting to be held on Wednesday May 15, 2024, at 6 p.m. in the company’s premises at Glödgargränd 14, Västerås, Sweden. RIGHT TO PARTICIPATE Shareholders wishing to attend the Annual General Meeting must: · partly be registered as shareholders in the share register held by

Checkin.com Group publishes Annual Report 2023

Checkin.com Group (STO:CHECK) today publishes its Annual Report for the financial year 2023. The Annual Report is attached to this press release and available on the company’s website: https://group.checkin.com/investors/reports/For further information, please contact: Jonas Köpniwsky, Head of Communications Checkin.com Group, press@checkin.com Certified Adviser Checkin.com Group’s Certified Adviser is Carnegie Investment Bank AB (publ). About Checkin.com Group Checkin.com Group creates shareholder value through capital efficient growth achieved by strong organic growth

Cereno Scientific expands patent protection for epigenetic HDAC inhibitor CS1:s second patent family

Cereno Scientific (Nasdaq First North: CRNO B), a pioneering biotech developing innovative treatments for rare and common cardiovascular disease, today announced that the Canadian authorities issued a patent for the drug candidate CS1:s second patent family on Tuesday April 9. This strengthens and expands the immaterial rights (IPR) for Cereno’s drug candidate CS1, which is currently in clinical Phase II development as a treatment of the rare disease Pulmonary Arterial Hypertension (PAH).“I am pleased to announce that we have secured further immaterial rights for the drug candidate CS1 in

There are no items matching the current filter
There are no more items matching the current filter
Back to top